Medical Use
Evrenzo is an anti-anemia medication used to treat adults with symptomatic anemia associated with chronic kidney disease (CKD).
Recommended Dosage:
- -Three Times Weekly Schedule: Evrenzo tablets come in a blister pack containing a 4-week supply (12 tablets), divided into four rows. Each row represents one week of medication (three tablets). Take tablets from the same row each week. The dosage can range from 20 mg three times weekly up to a maximum of 400 mg three times weekly.
- -Alternative Dosing Frequencies: Depending on hemoglobin levels, your doctor may adjust the dose to 20 mg two times or one time weekly. Your doctor will specify which days to take your dose.
- -Multiple Tablets for a Dose: Typically, patients will have one blister pack per month. If your dose requires more than one blister pack, you will need to take tablets from each pack on dosing days. Your healthcare provider will guide you on the exact number of tablets and when to take them.
Monitoring and Adjustments:
- -Hemoglobin Levels: Your hemoglobin levels will be regularly monitored. If they become too high, treatment with Evrenzo (20 mg/50 mg/70 mg/100 mg, or 150 mg) may be temporarily stopped. Do not restart treatment without your doctor’s approval.
Warning & Precautions
Use Evrenzo with Caution: Patients with a history of seizures, epilepsy, or conditions that predispose them to seizure activity, such as central nervous system (CNS) infections, should use Evrenzo cautiously.
Risk of Serious Infections: Serious infections, including pneumonia and urinary tract infections (UTIs), may occur. Patients showing signs or symptoms of infection should be promptly evaluated and treated according to standard medical practices.
Secondary Hypothyroidism: The use of Evrenzo (150 mg, 100 mg, 70 mg, 50 mg, or 20 mg) may lead to secondary hypothyroidism, which can be reversible upon discontinuation of the medication. Monitor thyroid function as needed.
Hepatic Impairment: Exercise caution when using Evrenzo in patients with moderate hepatic impairment (Child-Pugh class B). It is not recommended for patients with severe hepatic impairment (Child-Pugh class C).
Pregnancy: Evrenzo is contraindicated during the third trimester of pregnancy and should not be used during the first and second trimesters. If pregnancy is suspected while taking Evrenzo (70 mg or any other strength), discontinue treatment and consider alternative therapies.
Breastfeeding: It is unknown if Evrenzo or its metabolites are excreted in human milk. Based on animal studies, roxadustat may be present in milk. Therefore, avoid using this medication while breastfeeding.
Driving and Using Machines: This medication has minimal impact on the ability to drive or operate machinery. However, since seizures may occur during treatment, exercise caution when engaging in these activities.
Documentation Availability
Documents required to import EVRENZO to India?
EVRENZO (roxadustat) tablets can be imported by patients or treating physicians on behalf of patients. The following documentation is required to import the product:
- (i)2 ID proofs along with PAN card details along with attested scanned copies
- (ii)Valid doctor prescription scanned copy
- (iii)Doctor’s MCI number
- (iv)Doctor’s mobile number
- (v)Patients diagnostic reports
How is the order confirmed?
The order will be confirmed only after the receipt of:
- (i)The above-mentioned documents and drug availability.
- (ii)Import permit if applicable.
Sourcing & Delivery
The Rx4U team has extensive experience in sourcing EVRENZO (Cancer Treatment Medicines) around the world, ensuring global access to the best available treatments for our customers. We are dedicated to promptly dispensing any valid prescription. All prescriptions are verified and dispatched directly to the patient’s address. Our patients are our top priority, and we strive to improve their lives through our services.
FAQ
What is the Generic Name for Evrenzo®?
The generic name for Evrenzo® is Roxadustat.
Who Manufactures Evrenzo®?
Evrenzo® is manufactured by FibroGen, Inc.
Is Evrenzo® FDA Approved?
No, Evrenzo® is not approved by the FDA. It was approved by the European Union in August 2021.
What is the Dosage and Form of Evrenzo®?
Evrenzo® is available as tablets in the following strengths: 20 mg, 50 mg, 70 mg, 100 mg, and 150 mg for oral administration.
What are the Common Side Effects of Evrenzo®?
Common side effects include high blood pressure, diarrhea, peripheral edema, vascular access thrombosis, hyperkalemia, and nausea.
How Much Does Evrenzo® Cost in India?
The cost of Evrenzo® in India varies. To procure this anti-anemia medication authentically, you can reach out to Rx4u team.
How Should Evrenzo® be Stored?
Evrenzo® does not require any specific storage conditions.
How to order Evrenzo® online in India?
Evrenzo® can be ordered online in India through https://rx4u.in/.
*Disclaimer
All Trademarks and Brands that appear on the website belong to their respective owners and Rx4U does not lay any claim on them we only provide Information.
